(Q37952006)

25 August 2017

title

The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6). (English)

1 reference

25 August 2017

author

Eleftherios P. Diamandis

series ordinal

2

1 reference

25 August 2017

Jane Bayani

1

1 reference

25 August 2017

publication date

3 November 2011

1 reference

Clinical Chemistry and Laboratory Medicine

25 August 2017

published in

1 reference

25 August 2017

volume

50

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

211-233

1 reference

Biomarkers in cancer staging, prognosis and treatment selection

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The emerging roles of human tissue kallikreins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Functional roles of human kallikrein-related peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The new human tissue kallikrein gene family: structure, function, and association to disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The new human kallikrein gene family: implications in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Distribution of 15 human kallikreins in tissues and biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Role of kallikrein enzymes in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Structural role of Gly(193) in serine proteases: investigations of a G555E (GLY193 in chymotrypsin) mutant of blood coagulation factor XI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Evolutionary history of tissue kallikreins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Cloning of a kallikrein pseudogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that is expressed at lower levels in prostate cancer cells than in normal prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

A genomic analysis of rat proteases and protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Kallikrein-related peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Downregulation and CpG island hypermethylation of NES1/hK10 gene in the pathogenesis of human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

A coding polymorphism of the kallikrein 1 gene is associated with essential hypertension: a tagging SNP-based association study in a Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

MicroRNAs and cancer: profile, profile, profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Kallikreins as microRNA targets: an in silico and experimental-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Robust microRNA stability in degraded RNA preparations from human tissue and cell samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Gene expression and dental enamel structure in developing mouse incisor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

microRNAs: a new frontier in kallikrein research

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

In silico analysis of the human kallikrein gene 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Cloning and characterization of novel isoforms of the human kallikrein 6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Structural variation in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Towards a comprehensive structural variation map of an individual human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Complex controls: the role of alternative promoters in mammalian genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

MSP, a trypsin-like serine protease, is abundantly expressed in the human nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

RNA sequencing: advances, challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Increased expression of protease M in ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Potential markers that complement expression of CA125 in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The autolytic regulation of human kallikrein-related peptidase 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Activation profiles and regulatory cascades of the human kallikrein-related peptidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

A proteolytic cascade of kallikreins in the stratum corneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Recombinant kallikrein expression: site-specific integration for hK6 production in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Human kallikrein 13 expression in normal tissues: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Cellular distribution of human tissue kallikreins: immunohistochemical localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Expression of kallikrein-related peptidases (KRP/hK5, 7, 6, 8) in subtypes of human lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Genomic mechanisms and measurement of structural and numerical instability in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The landscape of somatic copy-number alteration across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The promoter of the prostate-specific antigen gene contains a functional androgen responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Tissue-specific expression of kallikrein family transgenes in mice and rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Identification and analysis of mammalian KLK6 orthologue genes for prediction of physiological substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The epigenetic basis for the aberrant expression of kallikreins in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The chemopreventive agent alpha-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Inhibition profiles of human tissue kallikreins by serine protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Molecular and biochemical characterization of a serine proteinase predominantly expressed in the medulla oblongata and cerebellar white matter of mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Potential scope of action of tissue kallikreins in CNS immune-mediated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Enzymatic properties of rat myelencephalon-specific protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Activity of a newly identified serine protease in CNS demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Functional role of kallikrein 6 in regulating immune cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Cell adhesion and communication proteins are differentially expressed in melanoma progression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Molecular analysis of anoikis resistance in oral cavity squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Proteinase-activated receptors, targets for kallikrein signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

International Union of Pharmacology. XXVIII. Proteinase-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Chronic inflammation, the tumor microenvironment and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Role of RAS in the regulation of PI 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

APP processing in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Human kallikrein 6 as a biomarker of alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Parkinson's Disease: Genetics and Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Extracellular neurosin degrades α-synuclein in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Differential expression of neuropsin and protease M/neurosin in oligodendrocytes after injury to the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Implications of protease M/neurosin in myelination during experimental demyelination and remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Diagnostic value of serum kallikrein-related peptidases 6 and 10 versus CA125 in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Ovarian carcinoma pathology and genetics: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Prospective study of serum micronutrients and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Status of tumor markers in epithelial ovarian cancer has there been any progress? A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Development of activity-based probes for trypsin-family serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Promise and challenge of RNA interference-based therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Retroviral display in gene therapy, protein engineering, and vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Association of Kallikrein Gene Polymorphisms With Intracranial Aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Human Kallikrein 6 Expression in Salivary Gland Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Characterization of Human Kallikreins 6 and 10 in Ascites Fluid from Ovarian Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

Elevated Human Tissue Kallikrein Levels in the Stratum Corneum and Serum of Peeling Skin Syndrome-Type B Patients Suggests an Over-desquamation of Corneocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.750

21 January 2018

Identifiers

DOI

10.1515/CCLM.2011.750

1 reference

25 August 2017

1 reference